The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Adjuvant capecitabine in locoregionally advanced nasopharyngeal carcinoma: A multicenter randomized controlled phase III trial.
 
Jingjing Miao
No Relationships to Disclose
 
Lin Wang
No Relationships to Disclose
 
Sze Huey Tan
No Relationships to Disclose
 
Jin-Gao Li
No Relationships to Disclose
 
Junlin Yi
No Relationships to Disclose
 
Ye Zhang
No Relationships to Disclose
 
Xiaochang Gong
No Relationships to Disclose
 
Xiang Yanqun
No Relationships to Disclose
 
Qiu-Yan Chen
No Relationships to Disclose
 
Mingyuan Chen
No Relationships to Disclose
 
Xing Lv
No Relationships to Disclose
 
Weixiong Xia
No Relationships to Disclose
 
Lin-Quan Tang
No Relationships to Disclose
 
Xiao-Wu Deng
No Relationships to Disclose
 
Xiang Guo
No Relationships to Disclose
 
Hai-Qiang Mai
No Relationships to Disclose
 
Fei Han
No Relationships to Disclose
 
Melvin Lee Kiang Chua
Stock and Other Ownership Interests - Varian Medical Systems (I)
Honoraria - Ferring; Janssen Oncology; Varian Medical Systems
Consulting or Advisory Role - Illumina; ImmunoSCAPE; Janssen Oncology; Merck Sharp & Dohme
Speakers' Bureau - AstraZeneca; Bayer; Pfizer
Research Funding - Decipher Biosciences; Ferring; PVmed; Varian Medical Systems
Travel, Accommodations, Expenses - Varian Medical Systems
(OPTIONAL) Uncompensated Relationships - Alice's Arc
 
Chong Zhao
No Relationships to Disclose